Aleena Banerji, Neelam A. Phadke, Ravi Gottumukkala, Rohit Sharma, Mandakolathur R. Murali: Case 8-2022: A 54-Year-Old Woman with Episodes of Swelling. New England Journal of Medicine 2022, Band 386, Ausgabe 11 vom 17. März 2022, Seiten 1071–1079, DOI: 10.1056/NEJMcpc2027087
Markus Magerl, Anastasios E. Germenis, Coen Maas, Marcus Maurer: Hereditary Angioedema with Normal C1 Inhibitor. In: Immunology and Allergy Clinics of North America. Band37, Nr.3, August 2017, S.571–584, doi:10.1016/j.iac.2017.04.004 (elsevier.com [abgerufen am 12. Februar 2020]).
M. Maurer, M. Magerl, I. Ansotegui, E. Aygören-Pürsün, S. Betschel: The international WAO/EAACI guideline for the management of hereditary angioedema-The 2017 revision and update. In: Allergy. Band73, Nr.8, August 2018, S.1575–1596, doi:10.1111/all.13384 (wiley.com [abgerufen am 12. Februar 2020]).
Jonathan A. Bernstein: On-demand Therapy for Hereditary Angioedema. In: Immunology and Allergy Clinics of North America. Band33, Nr.4, November 2013, S.487–494, doi:10.1016/j.iac.2013.07.004 (elsevier.com [abgerufen am 12. Februar 2020]).
Timothy Craig, Bruce Zuraw, Hilary Longhurst, Marco Cicardi, Konrad Bork: Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks. In: The Journal of Allergy and Clinical Immunology: In Practice. Band7, Nr.6, Juli 2019, S.1793–1802.e2, doi:10.1016/j.jaip.2019.01.054 (elsevier.com [abgerufen am 12. Februar 2020]).
Aleena Banerji, Marc A. Riedl, Jonathan A. Bernstein, Marco Cicardi, Hilary J. Longhurst: Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial. In: JAMA. Band320, Nr.20, 27. November 2018, ISSN0098-7484, S.2108, doi:10.1001/jama.2018.16773, PMID 30480729, PMC 6583584 (freier Volltext) – (jamanetwork.com [abgerufen am 12. Februar 2020]).
Francesca Perego, Maddalena A. Wu, Anna Valerieva, Sonia Caccia, Chiara Suffritti: Current and emerging biologics for the treatment of hereditary angioedema. In: Expert Opinion on Biological Therapy. Band19, Nr.6, 3. Juni 2019, ISSN1471-2598, S.517–526, doi:10.1080/14712598.2019.1595581 (tandfonline.com [abgerufen am 12. Februar 2020]).
elsevier.com
linkinghub.elsevier.com
Markus Magerl, Anastasios E. Germenis, Coen Maas, Marcus Maurer: Hereditary Angioedema with Normal C1 Inhibitor. In: Immunology and Allergy Clinics of North America. Band37, Nr.3, August 2017, S.571–584, doi:10.1016/j.iac.2017.04.004 (elsevier.com [abgerufen am 12. Februar 2020]).
Jonathan A. Bernstein: On-demand Therapy for Hereditary Angioedema. In: Immunology and Allergy Clinics of North America. Band33, Nr.4, November 2013, S.487–494, doi:10.1016/j.iac.2013.07.004 (elsevier.com [abgerufen am 12. Februar 2020]).
Timothy Craig, Bruce Zuraw, Hilary Longhurst, Marco Cicardi, Konrad Bork: Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks. In: The Journal of Allergy and Clinical Immunology: In Practice. Band7, Nr.6, Juli 2019, S.1793–1802.e2, doi:10.1016/j.jaip.2019.01.054 (elsevier.com [abgerufen am 12. Februar 2020]).
jamanetwork.com
jama.jamanetwork.com
Aleena Banerji, Marc A. Riedl, Jonathan A. Bernstein, Marco Cicardi, Hilary J. Longhurst: Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial. In: JAMA. Band320, Nr.20, 27. November 2018, ISSN0098-7484, S.2108, doi:10.1001/jama.2018.16773, PMID 30480729, PMC 6583584 (freier Volltext) – (jamanetwork.com [abgerufen am 12. Februar 2020]).
nih.gov
ncbi.nlm.nih.gov
Aleena Banerji, Marc A. Riedl, Jonathan A. Bernstein, Marco Cicardi, Hilary J. Longhurst: Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial. In: JAMA. Band320, Nr.20, 27. November 2018, ISSN0098-7484, S.2108, doi:10.1001/jama.2018.16773, PMID 30480729, PMC 6583584 (freier Volltext) – (jamanetwork.com [abgerufen am 12. Februar 2020]).
Francesca Perego, Maddalena A. Wu, Anna Valerieva, Sonia Caccia, Chiara Suffritti: Current and emerging biologics for the treatment of hereditary angioedema. In: Expert Opinion on Biological Therapy. Band19, Nr.6, 3. Juni 2019, ISSN1471-2598, S.517–526, doi:10.1080/14712598.2019.1595581 (tandfonline.com [abgerufen am 12. Februar 2020]).
wiley.com
doi.wiley.com
M. Maurer, M. Magerl, I. Ansotegui, E. Aygören-Pürsün, S. Betschel: The international WAO/EAACI guideline for the management of hereditary angioedema-The 2017 revision and update. In: Allergy. Band73, Nr.8, August 2018, S.1575–1596, doi:10.1111/all.13384 (wiley.com [abgerufen am 12. Februar 2020]).
Aleena Banerji, Marc A. Riedl, Jonathan A. Bernstein, Marco Cicardi, Hilary J. Longhurst: Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial. In: JAMA. Band320, Nr.20, 27. November 2018, ISSN0098-7484, S.2108, doi:10.1001/jama.2018.16773, PMID 30480729, PMC 6583584 (freier Volltext) – (jamanetwork.com [abgerufen am 12. Februar 2020]).
Francesca Perego, Maddalena A. Wu, Anna Valerieva, Sonia Caccia, Chiara Suffritti: Current and emerging biologics for the treatment of hereditary angioedema. In: Expert Opinion on Biological Therapy. Band19, Nr.6, 3. Juni 2019, ISSN1471-2598, S.517–526, doi:10.1080/14712598.2019.1595581 (tandfonline.com [abgerufen am 12. Februar 2020]).